Succinic anhydride → 1-(t-Butyloxycarbonyl)-4-(2-(4-hydroxy-4-oxo-butanoyloxy)ethyl)piperazine
Reaction equation
[OH:1][CH2:2][CH2:3][N:4]1[CH2:9][CH2:8][N:7]([C:10]([O:12][C:13]([CH3:16])([CH3:15])[CH3:14])=[O:11])[CH2:6][CH2:5]1.[C:17]1(=[O:23])[O:22][C:20](=[O:21])[CH2:19][CH2:18]1>CN(C)C1C=CN=CC=1.C(Cl)(Cl)Cl>[C:13]([O:12][C:10]([N:7]1[CH2:8][CH2:9][N:4]([CH2:3][CH2:2][O:1][C:17](=[O:23])[CH2:18][CH2:19][C:20]([OH:22])=[O:21])[CH2:5][CH2:6]1)=[O:11])([CH3:16])([CH3:15])[CH3:14]Participants
5
Procedure
Compound 57 (5.3 g, 23.0 mmol), succinic anhydride (2.30 g, 23.0 mmol) and 4-dimethylaminopyridine (281 mg, 2.30 mmol) were dissolved in CHCl3 (14 mL) and stirred for 18 h. The solution was concentrated in vacuo and used without further purification. 1H NMR (400 MHz, CDCl3) δ 1.42 (s, 9H), 2.54-2.60 (m, 8H), 2.72 (t, J=5.6, 2H), 3.43-3.46 (m, 4H), 4.23 (t, J=5.5, 2H).
Workup
- concentrationThe solution was concentrated in vacuo
- customused without further purification
Sources & evidence
- ORD record
- ord-d77c103601de4ddf90359c282e5ccddf
- Source dataset
- uspto-grants-2013_03
- Patent number
- US08404664B2
Reaction notes
Loading…